It has been reported that the high expression of STAT3 causes the occurrence of chemo-resistance and radio-resistance in human hepatocellular carcinoma (HCC) therapy; therefore, it is very important to discover anti-cancer agents that target STAT3 [1,7,13]. This evidence concerns the gene STAT3 and cancer.